InMed Pharmaceuticals Inc INM

InMed To Acquire BayMedica In All-Stock Transaction Pegged A

[AwareInvestor]

InMed Pharmaceuticals is looking to acquire one of its competitors. The firm has entered into a definitive agreement to acquire BayMedica Inc, a specialty firm focused on manufacturing and commercializing cannabinoids.

https://thedeepdive.ca/inmed-to-acquire-baymedica-in-all-stock-transaction-pegged-at-us3-7-million/

[MeanGreen]

Great to see this finally close. Hopefully a lot of other news and progress to follow. 

[Bullknit101]

Good news.

[Bullknit101]

Acquisition comes with a least one patent that has been approved: https://patents.google.com/patent/US10837031B2/en?assignee=Baymedica&oq=Baymedica+

[Bullknit101]

BayMedicas Chief Executive Officer, Shane Johnson, stated, The entire BayMedica team is very excited to join InMed. We look forward to advancing our manufacturing systems together, enabling us to bring additional rare cannabinoids to the market, and to leverage our technology and IP to directly contribute to InMeds clinical development pipeline. The timing of this acquisition is ideal given our

[Bullknit101]

"This transaction transforms InMed into a revenue-generating company, providing tangible value for our shareholders. BayMedica has demonstrated a rapid increase in sales since initiating commercialization, and we expect to grow these revenues considerably in the short-to-medium term. We believe this segment of the industry is reaching an inflection point as commercial viability is being